Malaysia vs Spain: Cause of death, by non-communicable diseases, ages 0-4, male
Malaysia
41.8%
in 2021
Spain
43.2%
in 2021
Malaysia rank
34th
Spain rank
32nd
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Malaysia
- Spain
How they compare
Spain currently reports 43.2% against 41.8% in Malaysia, a difference of 1.4%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Spain ahead.
Malaysia ranks 34th and Spain ranks 32nd of 185 countries.
Spain has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malaysia | Spain | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 40.7% | 47.0% | 6.3% | Spain |
| 2010s | 42.3% | 43.2% | 0.9% | Spain |
| 2020s | 42.2% | 43.8% | 1.5% | Spain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Malaysia or Spain?
- Spain, at 43.2% against 41.8% in Malaysia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Malaysia and Spain?
- 1.4%, with Spain ahead.
- How many years of comparable data are there for Malaysia and Spain?
- 6 years are reported by both, from 2000 to 2021.
- How do Malaysia and Spain rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Malaysia ranks 34th and Spain ranks 32nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.